Moneycontrol

Markets

  • Sensex
    35689.60
    257.21 (0.73%)
  • Nifty
    10821.85
    80.75 (0.75%)
you are here: Moneycontrol Mutual Funds Sector - Pharma & Healthcare Reliance Mutual Fund Reliance Pharma Fund - Direct Plan (G)

Reliance Pharma Fund - Direct Plan (G)

Plan: Direct | Option: Growth | Type : Open-Ended | AMFI Code: 118759
Buy
150.957 -1.19 ( -0.78 %)
NAV as on 21 Jun, 2018
Crisil MF Rank
Riskometer
HIGH
Success
Alert
Please select a Day.
Info

Not Ranked

The scheme is Not Ranked in Sector - Pharma & Healthcare category by Crisil (for quarter ended Mar 2018 ) from last quarter. If you are already invested in this scheme, you may continue to stay invested. But, do keep a check on its performance.

Chart

  • Benchmark Index

  • View Historic Graph

Returns (NAV as on Jun 21, 2018)
Period Returns(%) Rank#
1 Month 8.2 1
3 Months 7.5 1
6 Months 2.0 1
1 Year 13.9 1
2 Years 6.4 1
3 Years 4.2 1
5 Years 16.4 1

# Moneycontrol Rank within 12 Sector - Pharma & Healthcare Schemes

*Returns over 1 year are Annualised

* Calculation Remark - Dividends are reinvested at the rate of return

Absolute Returns (in %)
Year Qtr 1 Qtr 2 Qtr 3 Qtr 4 Annual
2018 -6.9 - - - -
2017 0.9 -5.7 0.1 12.4 8.3
2016 -12.1 2.5 6.7 -8.2 -9.6
2015 9.7 -4.2 14.5 -3.1 20.3
2014 3.7 11.0 25.3 3.6 49.6
2013 -6.3 5.6 3.4 14.8 21.1

View where it stands within its peers

Return Calculator SIP Calculator

Performance

Fund returns v/s Category average (Large Cap)

* Returns over 1 year are Annualised
  1mth(%) 3mth(%) 6mth(%) 1yr(%) 2yr(%) 3yr(%) 5yr(%)
Fund Returns 8.2 7.5 2 13.9 13.9 6.4 4.2
Category average 6.6 1.8 -4.5 1.5 -1.2 -1.4 9.8
Difference of Fund returns and Category returns 1.6 5.7 6.5 12.4 15.1 7.8 -5.6
Best of Category 8.2 7.5 2 13.9 6.4 4.2 16.4
Worst of Category 4.9 -3 -11.4 -7 -6.2 -5.5 10.9
Benchmark returns # 11.5 7.5 -0.8 1.7 -2 -4.2 0
Difference of Fund returns and Benchmark returns -3.3 0 2.8 12.2 15.9 10.6 4.2
# Benchmark Index: S&P BSE HEALTHCARE

Investment Information

Investment Objective

The primary investment objective of the scheme is to seek to generate consistent returns by investing in equity and equity related or fixed income securities of Pharma and other associated companies.

Registrars
Load Details
  • Entry Load:

    N.A

  • Exit Load:

    1.00%

  • Load Comments:

    Exit load - 1% if redeemed/switched out on or before completion of 1 yrs from the date of allotment.

Contact Details
peer comparison
Fund Crisil Rank Assets(Rs Cr.) Current NAV 3mth(%) 6mth(%) 1yr(%) 3yr(%) 5yr(%)
Reliance Pharma Fund (G) 1,695.82 144.4 7.3 1.6 12.9 3.2 15.4
Reliance Pharma Fund - Direct Plan (G) 258.39 151 7.5 2.0 13.9 4.2 16.4
SBI Healthcare Opportunities Fund (G) 828.41 115.9 -3.0 -11.4 -7.0 -5.5 12.9
SBI Healthcare Opportunities Fund - Direct Plan (G) 218.21 123 -2.7 -10.8 -5.8 -4.3 14.2
UTI Healthcare Fund (G) 362.92 83.5 0.0 -6.2 0.5 -3.1 10.9
*Returns over 1 year are Annualised

Portfolio

Top 10 Holdings As on May 31, 2018
Company Sector Value %Assets
Abbott India Pharmaceuticals 201.79 11.05
Sun Pharma Pharmaceuticals 178.50 10.47
Divis Labs Pharmaceuticals 212.95 9.77
Cipla Pharmaceuticals 188.37 9.26
Sanofi India Pharmaceuticals 171.40 8.89
Aurobindo Pharm Pharmaceuticals 155.76 8.08
Biocon Pharmaceuticals 153.30 7.95
Dr Reddys Labs Pharmaceuticals 117.61 6.94
Thyrocare Techn Services 133.79 6.10
Torrent Pharma Pharmaceuticals 94.36 4.89
Asset Allocation (%) As on May 31, 2018
Equity 99.24
Others 0.38
Debt 0.00
Mutual Funds 0.00
Money Market 0.77
Cash / Call -0.39
Sector Allocation (%) As on May 31, 2018
Sector %
Pharmaceuticals 85.28
Services 12.65
Manufacturing 1.25
Miscellaneous 0.06
Concentration As on May 31, 2018
Holdings %
Top 5 49.44
Top 10 99.24
Sectors %
Top 3 99.18
Forum | Add a comment...

See More

active boarders
arvind151

arvind151

Platinum Member

41998 Messages

See More

What`s Your Opinion

Will you invest in a IT-dedicated Mutual Fund scheme?

  • Yes
  • No

Submit

See More

Last Visited
Sections
Follow us on
Available On